Erlotinib Active Not Recruiting Phase 1 Trials for Neoplasms, Head and Neck / Cancer of Head and Neck Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention1
clinicaltrials.gov IdentifierTitleDrugs